Detect Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris for the First and Only Orally Administered Approved Medicine for the Diagnosis of Growth Hormone Deficiency in Adults - Iberonews

Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris for the First and Only Orally Administered Approved Medicine for the Diagnosis of Growth Hormone Deficiency in Adults - Iberonews
iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.

United kingdomOver rights from consilient healthAgreement coversEuropean economic areaAny future european commercial rightsPaediatric indications resulting fromDetect studyComplements existing endocrinology

Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris for the First and Only Orally Administered Approved Medicine for the Diagnosis of Growth Hormone Deficiency in Adults

The Agreement Covers the European Economic Area (EEA) and the UK Pharmanovia Will Take Over Rights From Consilient Health and Any Future European Commercial Rights for Paediatric Indications Resulting

United kingdomDennis riedlTracy mathisonKristine murrayAndrewr hoffmanDeno andrewsKlaus pauliniNicky kelepourisJames burtAlison dysonMaria fleseriuOver rights from consilient healthAeterna zentarisEuropean commissionNovo nordiskAgreement covers